PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitlePegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsJunyong Park